NCT05356936View on ClinicalTrials.gov

Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

August 1, 2024

Conditions
Post-acute COVID-19 Syndrome
Interventions
DIETARY_SUPPLEMENT

Vitamin K2 (MK-7)

Participants will receive Vitamin K2 (MK-7) daily by mouth.

DIETARY_SUPPLEMENT

Vitamin D3

Participants will receive Vitamin D3 daily by mouth.

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER